New Drugs No Better Than Older Ones for Sch...(etherlands; Robert A. Rosenheck M.D. pro...),Health
Navigation Links
New Drugs No Better Than Older Ones for Schizophrenia
Date:3/28/2008
etherlands; Robert A. Rosenheck, M.D., professor of psychiatry, Yale University School of Medicine, New Haven, Conn.; March 29, 2008, The Lancet
'/>"/>
| Copyright©2008 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. Americans Guess One-Third of Professional Athletes on Performance Enhancing Drugs
2. Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa
3. Drugs Approved Under Deadline More Likely to Run Into Trouble Later
4. NSAIDs: Painkillers, inflammation inhibitors, anti-cancer drugs and new de-methylating agents
5. PCMA: Independent Drugstore Lobbys Prompt Pay Agenda Could Cost Medicare $3.3 Billion Over the Next Decade
6. China Nepstar Chain Drugstore Announces Dividend
7. Significant Generic Erosion Will Cause Sales of Dyslipidemia Drugs to Decline by $3.6 Billion by 2016
8. China Nepstar Chain Drugstore Reports 231.5% Increase in Net Income and Record Gross Margin of 48.5% for Fourth Quarter 2007
9. Baxa Corporation Announces Safe Handling and Preparation of Hazardous Drugs Course Offering at its STAR Center Training Facility
10. Wal-Mart Saves Customers More Than $1 Billion On Prescription Drugs
11. FDA Panel Supports Anemia Drugs for Cancer Patients
Post Your Comments:
Related Image:
 New Drugs No Better Than Older Ones for Schizophrenia |
(Date:11/24/2009)... , Sinusitis patients lif...nic sinusitis, Sinus Dynamics non-invasive nasal s...venience of treating all types of Sinusitis withou...ny sinus surgery. Researchers found 82.9% of patie...ized antibiotics with mean particle diameter of 3....
(Date:11/24/2009)... ,, WASHINGTON,Nov.24/PRNewswire-USNewswire/...hofthenearly4millionAmericansinfectedwithchroniche...yearsshouldbeawake-upcallthatCongressneedstomoveur...eddetection,research,andsurveillanceefforts,the Na..., TheNVHRwarnsthatwithoutcongressionalaction,mil...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)... , After suffering from w...losi,s hair is growing back and she,s sharing her ...ousands of other women through the release of her ... her hair before and during her treatment. , ...- Long-time hair loss sufferer Zsanett Siklosi h...
(Date:11/23/2009)... ,, HATBORO,Pa.,Nov.23/PRNewswire-FirstCall/...providerofenterprisemobilitysolutionsforthehealthc...y,formerVicePresidentofManagedServicesatSiemensHea...ategicHealthcareServices. ,, (Logo: http://www...., AsVicePresidentofStrategicHealthcareServicesfo...
Breaking Medicine News(10 mins):Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3[0] Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery [0] NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington[0] AUDIO from Medialink and Pfizer Inc.: Reduce Holiday Stress to Help Ease Fibromyalgia[1] Women's Hair Loss Treatment Results Captured on Video to Inspire Others[0] Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services
... Air Products (NYSE: APD ) announced today that ...hn E. McGlade will be presenting at the Goldman Sa...sday, June 4, 2009, at 8:00 a.m. EDT. , , An aud...tm . , , Air Products (NYSE: APD ) serves cust...
...Sally Kwak, economics professors at the University... Economics and Human Biology titled, "Weight Gai...amines trends in adolescent body mass index (BMI) ...ir friends, even after controlling for confounding...
... SMOS, has just passed the all-important Flight Ac...that make up the mission are in place for launch l...for its journey to the Plesetsk Cosmodrome in nort...ements not only include the satellite, but also th...
...t Work, the first company to enable physician serv...icine technology, has secured full-time physician ...ed by emergency medicine and internal medicine phy...bines innovative medical instruments, telecommunic...
... 28 Transcept Pharmaceuticals, Inc. (Nasdaq: TS...n the development and commercialization of proprie...eeds in the field of neuroscience, announced today...k City on Wednesday, June 10, 2009 at 3:00 p.m., E...
...sue of Ostomy Wound Management(1) , , SKILLMAN, ...le living with an ostomy reported very high levels...pioneered by ConvaTec Ostomy Care, according to re...technologies for community and hospital care, deve...
Other Medicine News:Health News:SMOS ready to ship to launch site 2Health News:Not Feeling Well? Can't Leave the Office? The Doctor Will See You Now 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 2Health News:Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009 3Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 2Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 3Health News:Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier 4Air Products' CEO to Address Goldman Sachs Basic Materials Conference on 4 JuneUniversity of Hawaii at Manoa professors co-author adolescent obesity studySMOS ready to ship to launch siteNot Feeling Well? Can't Leave the Office? The Doctor Will See You NowTranscept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2[0] Noted Diagnostic Radiologists Joan Werber, D.O., Ahmed Farag, M.D., C.M., Join Forces to Create Diagnostic Imaging Specialists of Chicago[0] NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference[0] Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Chemstrip Micral
QED A350 Saliva Alcohol Test
AccuSign DOA Series Tests
...highly accurate in detecting the presence of drugs... GC/MS testing. This assay provides a preliminary ...uch as GC/MS) must be used in order to obtain a co...plied to any drug of abuse test result, particular...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |